Optimising Intratumoral Treatment of Head and Neck Squamous Cell Carcinoma Models With the Diterpene Ester Tigilanol Tiglate

Investigational New Drugs- Netherlands

doi 10.1007/s10637-018-0604-y

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Head and Neck Squamous Cell Carcinoma in Pregnant Women

Laryngoscope
Otorhinolaryngology
2011English

Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma

Practical Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Pulmonary Squamous Cell Carcinoma Following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary?

Clinical Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy